genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2012
ExonHit Therapeutics
News
Exonhit Joins €6M EU Consortium to Develop Tests for Predicting Avastin, Herceptin Response
News
ExonHit Gets EC Clearance for Alzheimer Disease In Vitro Diagnostic
Cancer
ExonHit Backs Out of $22.5M Agreement to Acquire RedPath Integrated Pathology
Cancer
Genmab Gains 10 Breast Cancer Targets from ExonHit
Cancer
ExonHit and bioMérieux Scrap Colorectal Cancer from Biomarker Discovery Program
News
ExonHit Joins EU’s PharmaCog Alzheimer Disease Consortium
Cancer
ExonHit Licenses IP for Breast Cancer Test from Institut Gustave Roussy
News
Allergan and ExonHit Broaden Partnership to Include Ocular Diseases
Best of the Web
ExonHit
Insights
Revamping Drug Discovery Strategies
1
2
Page 1 of 2
Scroll Up
Scroll Up
